These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23847445)
41. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells. Shi K; Ru Q; Zhang C; Huang J Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391 [TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway. Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318 [No Abstract] [Full Text] [Related]
43. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M; Li M; Wang T; Linghu E; Wu B Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501 [TBL] [Abstract][Full Text] [Related]
45. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma. Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071 [TBL] [Abstract][Full Text] [Related]
46. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q; Cai W; Zhang M; Liu Q; Liu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562 [TBL] [Abstract][Full Text] [Related]
47. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Li X; Pan Y; Fan R; Jin H; Han S; Liu J; Wu K; Fan D Carcinogenesis; 2008 Aug; 29(8):1587-93. PubMed ID: 18299278 [TBL] [Abstract][Full Text] [Related]
48. MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3. Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B Int J Oncol; 2015 Oct; 47(4):1585-93. PubMed ID: 26252738 [TBL] [Abstract][Full Text] [Related]
49. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735 [TBL] [Abstract][Full Text] [Related]
50. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells]. Qin AD; Liu XX; Li J; Liu J; Li YS Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764 [No Abstract] [Full Text] [Related]
51. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. Li YH; Liu Y; Li YD; Liu YH; Li F; Ju Q; Xie PL; Li GC World J Gastroenterol; 2012 Jun; 18(21):2704-11. PubMed ID: 22690081 [TBL] [Abstract][Full Text] [Related]
52. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168 [TBL] [Abstract][Full Text] [Related]
53. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker? Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624 [TBL] [Abstract][Full Text] [Related]
54. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin]. He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357 [TBL] [Abstract][Full Text] [Related]
55. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Moon WS; Tarnawski AS Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813 [TBL] [Abstract][Full Text] [Related]
56. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway. Yang B; Zhao J; Huo T; Zhang M; Wu X J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578 [TBL] [Abstract][Full Text] [Related]
57. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth. Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629 [TBL] [Abstract][Full Text] [Related]
58. Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma. Fan H; Zhao ZJ; Cheng J; Su XW; Wu QX; Shan YF World J Gastroenterol; 2009 Apr; 15(16):2020-6. PubMed ID: 19399937 [TBL] [Abstract][Full Text] [Related]
59. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
60. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]